Wednesday, December 2, 2015   

(Football) Hamburg signs Lasogga from Hertha Berlin
(07-04 16:55)

Hamburger SV signed forward Pierre-Michel Lasogga on a five-year contract from Bundesliga rival Hertha Berlin after he spent a season on loan at the club. It also sold midfielder Hakan Calhanoglu to Bayer Leverkusen on Friday.
The 22-year-old Lasogga's goal in the second leg of a relegation playoff in May salvaged the top-flight status of the club, the only one never to have been relegated in the Bundesliga's 51-year history. Hamburg didn't give details of the permanent transfer deal.
Also, Leverkusen announced it signed Calhanoglu, a 20-year-old who has played for Turkey, on a five-year deal subject to a medical.
Leverkusen finished fourth last season, giving it a chance to qualify for this season's Champions League. It said Calhanoglu wanted a chance to prove himself in European competition. --AP   
Other Sports breaking news:
(NBA) 19-0 and counting for Warriors (12-01 19:00)
(Football) Benzema should not wear French colors, PM says (12-01 18:50)
(Rugby Union) Final service honors Jonah Lomu’s life (12-01 16:41)
(Baseball) Bonds wants Marlins coaching job (12-01 16:33)
(NHL) First starter Sparks marks shutout milestone (12-01 16:29)
(NFL) Broncos bounce back to spoil Patriots perfect season (11-30 15:47)
(Serie A) Roma humbled, again (11-30 15:42)
(French league) Caen rout Bordeaux (11-30 14:30)
(Spanish league) Real Madrid break dry run (11-30 14:25)
(NBA) Kobe Bryant: ‘my body knows it's time to say goodbye’ (11-30 14:16)

More breaking news >>

© 2015 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2015, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.